353
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China

, , , , , , & show all
Pages 1443-1449 | Accepted 11 Mar 2010, Published online: 15 Apr 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Glenn S. Tillotson & Stephen H. Zinner. (2017) Burden of antimicrobial resistance in an era of decreasing susceptibility. Expert Review of Anti-infective Therapy 15:7, pages 663-676.
Read now
Giannoula S Tansarli, Drosos E Karageorgopoulos, Anastasios Kapaskelis & Matthew E Falagas. (2013) Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence. Expert Review of Anti-infective Therapy 11:3, pages 321-331.
Read now

Articles from other publishers (15)

Yihong Sun, Jia Fan, Gang Chen, Xiaofei Chen, Xiaoling Du, Ye Wang, Hui Wang, Fang Sun, Matthew G. Johnson, Mekki Bensaci, Jennifer A. Huntington & Christopher J. Bruno. (2022) A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infections. International Journal of Infectious Diseases 123, pages 157-165.
Crossref
Xuemei Zhen, Cecilia Stålsby Lundborg, Xueshan Sun, Xiaoqian Hu & Hengjin Dong. (2020) Clinical and Economic Impact of Third-Generation Cephalosporin-Resistant Infection or Colonization Caused by Escherichia coli and Klebsiella pneumoniae: A Multicenter Study in China. International Journal of Environmental Research and Public Health 17:24, pages 9285.
Crossref
I. López-Montesinos, A. Domínguez-Guasch, S. Gómez-Zorrilla, X. Duran-Jordà, A. Siverio-Parès, M.M. Arenas-Miras, M.M. Montero, L. Sorli Redó, S. Grau & J.P. Horcajada. (2020) Clinical and economic burden of community-onset multidrug-resistant infections requiring hospitalization. Journal of Infection 80:3, pages 271-278.
Crossref
Xuemei Zhen, Cecilia Stålsby Lundborg, Xueshan Sun, Xiaoqian Hu & Hengjin Dong. (2019) Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review. Antimicrobial Resistance & Infection Control 8:1.
Crossref
Zhen, Lundborg, Sun, Hu & Dong. (2019) The Clinical and Economic Impact of Antibiotic Resistance in China: A Systematic Review and Meta-Analysis. Antibiotics 8:3, pages 115.
Crossref
Emily M. Eichenberger & Joshua T. Thaden. (2019) Epidemiology and Mechanisms of Resistance of Extensively Drug Resistant Gram-Negative Bacteria. Antibiotics 8:2, pages 37.
Crossref
Tolbert Sonda, Happiness Kumburu, Marco van Zwetselaar, Michael Alifrangis, Blandina T. Mmbaga, Ole Lund, Gibson S. Kibiki & Frank M. Aarestrup. (2018) Molecular epidemiology of virulence and antimicrobial resistance determinants in Klebsiella pneumoniae from hospitalised patients in Kilimanjaro, Tanzania. European Journal of Clinical Microbiology & Infectious Diseases 37:10, pages 1901-1914.
Crossref
Xuemei Zhen, Yuanyuan Li, Yixi Chen, Peng Dong, Stephanie Liu & Hengjin Dong. (2018) Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China. PLOS ONE 13:3, pages e0193977.
Crossref
Joshua T. Thaden, Yanhong Li, Felicia Ruffin, Stacey A. Maskarinec, Jonathan M. Hill-Rorie, Lisa C. Wanda, Shelby D. Reed & Vance G. FowlerJr.Jr.. (2017) Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections. Antimicrobial Agents and Chemotherapy 61:3.
Crossref
J.A. Maslikowska, S.A.N. Walker, M. Elligsen, N. Mittmann, L. Palmay, N. Daneman & A. Simor. (2016) Impact of infection with extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella species on outcome and hospitalization costs. Journal of Hospital Infection 92:1, pages 33-41.
Crossref
Patricia Cornejo-Juárez, Juan Antonio Suárez-Cuenca, Patricia Volkow-Fernández, Jesús Silva-Sánchez, Humberto Barrios-Camacho, Esmeralda Nájera-León, Consuelo Velázquez-Acosta & Diana Vilar-Compte. (2015) Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies. Supportive Care in Cancer 24:1, pages 253-259.
Crossref
R. Leistner, S. Gürntke, C. Sakellariou, L. A. Denkel, A. Bloch, P. Gastmeier & F. Schwab. (2014) Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort. Infection 42:6, pages 991-997.
Crossref
Cheol-In KangJae-Hoon Song. (2013) Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implications. Infection & Chemotherapy 45:1, pages 22.
Crossref
Uri Obolski & Lilach Hadany. (2012) Implications of stress-induced genetic variation for minimizing multidrug resistance in bacteria. BMC Medicine 10:1.
Crossref
Patricia Cornejo-Juárez, Carolina Pérez-Jiménez, Jesús Silva-Sánchez, Consuelo Velázquez-Acosta, Fernanda González-Lara, Fernando Reyna-Flores, Alejandro Sánchez-Pérez & Patricia Volkow-Fernández. (2012) Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum β-Lactamase Bloodstream Infection in Hematological Malignancies. PLoS ONE 7:4, pages e35780.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.